Cite
HARVARD Citation
Bijl, H. et al. (n.d.). EP-1812: Adaptive VMAT for cT1-2aN0M0 laryngeal cancer: potential risk of target volume over dosage. Radiotherapy and oncology. pp. S850-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bijl, H. et al. (n.d.). EP-1812: Adaptive VMAT for cT1-2aN0M0 laryngeal cancer: potential risk of target volume over dosage. Radiotherapy and oncology. pp. S850-. [Online].